pRb and E2f-1 in mouse development and tumorigenesis

Dyson, 1998, The regulation of E2F by pRB-family members, Genes Dev, 12, 2245, 10.1101/gad.12.15.2245

Mulligan, 1998, The retinoblastoma gene family: cousins with overlapping interests, Trends Genet, 14, 223, 10.1016/S0168-9525(98)01470-X

Lee, 1998, Structure of the retinoblastoma tumor-suppressor pocket domain bound to a peptide from HPV E7, Nature, 391, 859, 10.1038/36038

Morkel, 1997, An E2F-like repressor of transcription, Nature, 390, 567, 10.1038/37507

Trimarchi, 1998, E2F-6, a member of the E2F family that can behave as a transcriptional repressor, Proc Natl Acad Sci USA, 95, 2850, 10.1073/pnas.95.6.2850

Gaubatz, 1998, Unusual proliferation arrest and transcriptional control properties of a newly discovered E2F family member, E2F-6, Proc Natl Acad Sci USA, 95, 9190, 10.1073/pnas.95.16.9190

Altiok, 1997, PPARγ induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A, Genes Dev, 11, 1987, 10.1101/gad.11.15.1987

Verona, 1997, E2F activity is regulated by cell cycle-dependent changes in subcellular localisation, Mol Cell Biol, 17, 7268, 10.1128/MCB.17.12.7268

Hofmann, 1996, The retinoblastoma gene product protects E2F-1 from degradation by the ubiqutin-proteasome pathway, Genes Dev, 10, 2949, 10.1101/gad.10.23.2949

Hateboer, 1996, Degradation of E2F by the ubiquitin-proteasome pathway: regulation by retinoblastoma family proteins and adenovirus transforming proteins, Genes Dev, 10, 2960, 10.1101/gad.10.23.2960

Brehm, 1998, Retinoblastoma protein recruits histone deacetylase to repress transcription, Nature, 391, 597, 10.1038/35404

Magnaghi-Jaulin, 1998, Retinoblastoma protein represses transcription by recruiting a histone deacetylase, Nature, 391, 601, 10.1038/35410

Luo, 1998, Rb interacts with histone deacetylase to repress transcription, Cell, 92, 463, 10.1016/S0092-8674(00)80940-X

DeGregori, 1997, Distinct roles for E2F proteins in cell growth control and apoptosis, Proc Natl Acad Sci USA, 94, 7245, 10.1073/pnas.94.14.7245

Kowalik, 1998, E2F-1 specific induction of apoptosis and p53 accumulation which is blocked by mdm2, Cell Growth Diff, 9, 113

Hurford, 1997, pRB and p107/p130 are required for the regulated expression of different sets of E2F responsive genes, Genes Dev, 11, 1447, 10.1101/gad.11.11.1447

Jacks, 1992, Effects of an Rb mutation in the mouse, Nature, 359, 295, 10.1038/359295a0

Lee, 1992, Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis, Nature, 359, 288, 10.1038/359288a0

Clarke, 1992, Requirement for a functional Rb-1 gene in murine development, Nature, 359, 328, 10.1038/359328a0

Lee, 1994, Dual Roles of the retinoblastoma protein in cell cycle regulation and neuron differentiation, Genes Dev, 8, 2008, 10.1101/gad.8.17.2008

Morgenbesser, 1994, p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens, Nature, 371, 72, 10.1038/371072a0

Macleod, 1996, Loss of Rb activates both p53-dependent and -independent cell death pathways in the developing mouse nervous system, EMBO J, 15, 6178, 10.1002/j.1460-2075.1996.tb01006.x

Lee, 1996, Targeted disruption of p107: functional overlap between p107 and Rb, Genes Dev, 10, 1621, 10.1101/gad.10.13.1621

Cobrinik, 1996, Shared role of the pRB-related p130 and p107 proteins in limb development, Genes Dev, 10, 1633, 10.1101/gad.10.13.1633

Jiang, 1997, The retinoblastoma gene family is differentially expressed during embryogenesis, Oncogene, 14, 1789, 10.1038/sj.onc.1201014

Zacksenhaus, 1996, pRb controls proliferation, differentiation, and death of skeletal muscle cells and other lineages during embryogenesis, Genes Dev, 10, 3051, 10.1101/gad.10.23.3051

Yamasaki, 1996, Tumor induction and tissue atrophy in mice lacking E2F-1, Cell, 85, 537, 10.1016/S0092-8674(00)81254-4

Field, 1996, E2F-1 functions in mice to promote apoptosis and suppress proliferation, Cell, 85, 549, 10.1016/S0092-8674(00)81255-6

Nikitin, 1996, Early loss of the retinoblastoma gene is associated with impaired growth inhibitory innervation during melanotroph carcinogenesis in Rb+/– mice, Genes Dev, 10, 1870, 10.1101/gad.10.15.1870

Pan, 1994, Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development, Genes Dev, 8, 1285, 10.1101/gad.8.11.1285

Pan, 1995, Temporally distinct patterns of p53-dependent and p53-independent apoptosis during mouse lens development, Genes Dev, 9, 2157, 10.1101/gad.9.17.2157

Howes, 1994, Apoptosis or retinoblastoma: alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53, Genes Dev, 8, 1300, 10.1101/gad.8.11.1300

Symonds, 1994, p53-dependent apoptosis suppresses tumor growth and progression in vivo, Cell, 78, 703, 10.1016/0092-8674(94)90534-7

Johnson, 1994, Oncogenic capacity of the E2F-1 gene, Proc Natl Acad Sci USA, 91, 12823, 10.1073/pnas.91.26.12823

Guy, 1996, E2F-1 blocks terminal differentiation and causes proliferation in transgenic megakaryocytes, Mol Cell Biol, 16, 685, 10.1128/MCB.16.2.685

Vooijs, 1998, Flp-mediated tissue specific inactivation of the retinoblastoma tumor suppressor gene in the mouse, Oncogene, 17, 1, 10.1038/sj.onc.1202169

Pierce, 1998, Increased E2F-1 activity induces skin tumors in mice heterozygous and nullizygous for p53, Proc Natl Acad Sci USA, 95, 8858, 10.1073/pnas.95.15.8858

Pierce, 1998, Deregulated expression of E2F-1 induces hyperplasia and cooperates with ras in skin tumor development, Oncogene, 16, 1267, 10.1038/sj.onc.1201666

Yamasaki, 1998, Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1+/– mice, Nat Genet, 18, 360, 10.1038/ng0498-360

Pan, 1998, A key role for E2F-1 in p53-dependent apoptosis and cell division within developing tumors, Mol Cell, 2, 293, 10.1016/S1097-2765(00)80273-7

Tsai, 1998, Mutation of E2f-1 suppresses apoptosis and inappropriate S-phase entry and extends survival of Rb-deficient mouse embryos, Mol Cell, 2, 283, 10.1016/S1097-2765(00)80274-9

Hueber, 1998, Traps to catch unwary oncogenes, Trends Genet, 14, 364, 10.1016/S0168-9525(98)01520-0

Zhang, 1998, ARF promotes mdm2 degradation and stabilises p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways, Cell, 92, 725, 10.1016/S0092-8674(00)81401-4

Pomerantz, 1998, The Ink4a tumor suppressor gene product p19ARF interacts with mdm2 and neutralises mdm2’s inhibition of p53, Cell, 92, 713, 10.1016/S0092-8674(00)81400-2

Kamijo, 1998, Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2, Proc Natl Acad Sci USA, 95, 8292, 10.1073/pnas.95.14.8292

de Stanchina, 1998, E1A signalling to p53 involves the 19ARF tumor suppressor, Genes Dev, 12, 2434, 10.1101/gad.12.15.2434

Zindy, 1998, Myc signalling via the ARF tumor suppressor regulates p53-dependent apoptosis, Genes Dev, 12, 2424, 10.1101/gad.12.15.2424

Palmero, 1998, p19ARF links the tumor suppressor p53 to Ras, Nature, 395, 125, 10.1038/25870

Bates, 1998, p14ARF links the tumor suppressors RB and p53, Nature, 395, 124, 10.1038/25867

Leone, 1998, E2F3 activity is regulated during the cell cycle and is required for the induction of S phase, Genes Dev, 12, 2120, 10.1101/gad.12.14.2120

Hsieh, 1997, E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction, Genes Dev, 11, 1840, 10.1101/gad.11.14.1840

Phillips, 1997, Induction of DNA synthesis and apoptosis are separable functions of E2F-1, Genes Dev, 11, 1853, 10.1101/gad.11.14.1853

Zhang, 1998, Cooperation between the cdk inhibitors p27KIP1 and p57KIP2 in the control of tissue growth and development, Genes Dev, 12, 3162, 10.1101/gad.12.20.3162

Janicke, 1996, Specific cleavage of the retinoblastoma protein by an ICE-like protease in apoptosis, EMBO J, 15, 6969, 10.1002/j.1460-2075.1996.tb01089.x

Robanus-Maandag, 1994, Developmental rescue of an embryonic-lethal mutation in the retinoblastoma gene in chimeric mice, EMBO J, 13, 4260, 10.1002/j.1460-2075.1994.tb06746.x

Williams, 1994, Extensive contribution of Rb-deficient cells to adult chimeric mice with limited histopathological consequences, EMBO J, 13, 4251, 10.1002/j.1460-2075.1994.tb06745.x

Chen, 1996, Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interactions with C/EBPs, Genes Dev, 10, 2794, 10.1101/gad.10.21.2794

Gu, 1993, Interaction of myogenic factors and the retinblastoma protein mediates muscle cell commitment and differentiation, Cell, 72, 309, 10.1016/0092-8674(93)90110-C

Schneider, 1994, Reversal of terminal differentiation mediated by p107 in Rb–/– muscle cells, Science, 264, 1467, 10.1126/science.8197461

Novitch, 1996, Skeletal muscle cells lacking the retinoblastoma protein display defects in muscle gene expression and accumulate in S phase and G2 phases of the cell cycle, J Cell Biol, 135, 441, 10.1083/jcb.135.2.441

Sellers, 1998, Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation and suppress tumor cell growth, Genes Dev, 12, 95, 10.1101/gad.12.1.95

Samuelson, 1997, Selective induction of p53 and chemosensitivity in RB-deficient cells by E1a mutants unable to bind the RB-related proteins, Proc Natl Acad Sci USA, 94, 12094, 10.1073/pnas.94.22.12094

Robanus-Maandag, 1998, p107 is a suppressor of retinoblastoma development in Rb-deficient mice, Genes Dev, 12, 1599, 10.1101/gad.12.11.1599

White, 1997, Regulation of RNA polymerases I and III by the retinoblastoma protein: a mechanism for growth control?, Trends Biochem Sci, 22, 77, 10.1016/S0968-0004(96)10067-0